KPTIQ

0.03157.08%
RA

Richard A. Paulson

President, CEO & Director

Mr. Richard A. Paulson, M.B.A. has been a Director of Karyopharm Therapeutics Inc. since February 26, 2020 and has been its Chief Executive Officer and President since May 3, 2021. Mr. Paulson has been an Independent Director of bluebird bio, Inc. since April 3, 2023. He had been Chief Executive Officer of North America at Ipsen S.A. since February 5, 2018 and served as its Executive Vice-President since February 5, 2018 until May 2020. Mr. Paulson served an Executive Vice President of Ipsen Pharmaceuticals, Inc., a biopharmaceutical company. Mr. Paulson was Executive Vice-President and Chief Executive Officer of Ipsen North America from February 2018 to May 2021. He joined Ipsen from Amgen where he served as Vice-President and General Manager of the Oncology Business Unit from 2015 to 2018. During a 10-year career at Amgen, he held several positions in the company, including General Manager, Central and Eastern Europe and subsequently General Manager Germany, before assuming leadership positions in Amgen’s Oncology Business Unit. Prior to joining Amgen, he held international positions in general management, marketing and market access with Pfizer. He also served in several sales and marketing roles with increasing seniority for GlaxoWellcome in Canada. Mr. Paulson has a wealth of leadership and global strategic experience as he has served in the leadership of some of the industry’s most innovative and commercially successful pharmaceutical companies. Mr. Paulson has years of global biopharmaceutical industry experience, including various international leadership roles transforming organizations and developing highly successful teams across three continents, where he has launched best-in-class products across multiple therapeutic areas including oncology medicines. At Ipsen North America, he is responsible for driving continued growth in both the U.S. and Canadian markets across key therapeutics areas of oncology, neurology and rare diseases. He is a member of the BIO Health Section Governing Board (HSGB) and an interim director on the PhRMA Board of Directors. He holds an MBA from the University of Toronto. Mr. Paulson earned Bachelor in Commerce in marketing and finance from the University of Saskatchewan, Canada.

Positions